Document Type
Article
Publication Date
5-24-2012
Publication Source
U.S. Patent and Trademark Office
Abstract
The invention relates to the identification of new polypeptide and protein variants of fibroblast growth factor 21 (FGF21) that have improved pharmaceutical properties. Also disclosed are methods for treating FGF21-associated disorders, includ ing metabolic conditions.
eCommons Citation
Boettcher, Brian R.; Caplan, Shari L.; Daniels, Douglas S.; Geierstanger, Bernhard Hubert; Hamamatsu, Norio; Licht, Stuart; Loew, Andreas; and Weldon, Stephen Craig, "Patent: Methods of Treating FGF21-Associated Disorders" (2012). Chemistry Faculty Publications. 101.
https://ecommons.udayton.edu/chm_fac_pub/101
Comments
Pub. No.: US 2012/0129766A1